News-Medical.Net on MSN
Combined GLP-1 and GLP-2 treatment appears safe but does not beat placebo for obesity
By Hugo Francisco de Souza Can combining two gut hormone pathways unlock better obesity treatments? In the first human trial ...
Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...
The glucagon-like peptides (GLP-1 and GLP-2) are processed from the proglucagon polypeptide and secreted in equimolar amounts but have opposite effects on chylomicron (CM) production, with GLP-1 ...
Trends shaping GLP-1 landscape include FDA regulatory updates, rapid oral drug adoption, and shifting clinical evidence for diabetes care.
GLP-1RA therapy vs metformin may offer time-dependent neuroprotection against Parkinson disease among patients with type 2 diabetes.
Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
Some GLP-1 patients are begging to stay on the drugs just a little bit longer, presenting an ethical dilemma for doctors.
Find out more about how GLP-1RAs are associated with a reduced risk of aneurysmal rupture in high-risk patient populations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results